The single blind randomized control trial for preventing post-ERCP pancreatitis by NSAID injection, flurbiprofen

The single blind randomized control trial for preventing post-ERCP pancreatitis by NSAID injection, flurbiprofen - Trail for injecting flurbiprofen to prevent post-ERCP pancreatitis

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009121

Enrollment

398

Registered

2012-10-15

Start date

2012-10-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-ERCP pancreatitis

Interventions

intravenous injection of flurbiprofen 50mg after ERCP intravenous injection of physiological saline after ERCP

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: people who understand the contents of this research aims and methods before ERCP

Exclusion criteria

Exclusion criteria: people who does not understand the contents of this research aims and methods before ERCP

Design outcomes

Primary

Measure	Time frame
incidence and severity of post-ERCP pancreatitis	—

Countries

Japan

Contacts

Public ContactHajime Higuchi

School of Medicine, Keio University Gastroenterology & Hepatology

higuchi@a2.keio.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026